Loading clinical trials...
Loading clinical trials...
This is an observational screening study to evaluate the prevalence of anti-adeno-associated serotype 8 (AAV8) antibodies in participants with Duchenne muscular dystrophy (DMD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
REGENXBIO Inc.
NCT06817382 · Duchenne Muscular Dystrophy
NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)
NCT07037862 · Duchenne Muscular Dystrophy (DMD)
NCT07160634 · Duchenne Muscular Dystrophy
NCT06450639 · Duchenne Muscular Dystrophy
Rare Disease Research
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions